Welcome to P K Kelkar Library, Online Public Access Catalogue (OPAC)

High-Grade Gliomas (Record no. 503300)

000 -LEADER
fixed length control field 03817nam a22004575i 4500
001 - CONTROL NUMBER
control field 978-1-59745-185-7
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20161121230736.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100301s2007 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781597451857
-- 978-1-59745-185-7
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-59745-185-7
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RD592.5-596
072 #7 - SUBJECT CATEGORY CODE
Subject category code MNN
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED085010
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 617.48
Edition number 23
245 10 - TITLE STATEMENT
Title High-Grade Gliomas
Medium [electronic resource] :
Remainder of title Diagnosis and Treatment /
Statement of responsibility, etc. edited by Gene H. Barnett.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Totowa, NJ :
Name of producer, publisher, distributor, manufacturer Humana Press,
Date of production, publication, distribution, manufacture, or copyright notice 2007.
300 ## - PHYSICAL DESCRIPTION
Extent XIII, 495 p.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
490 1# - SERIES STATEMENT
Series statement Current Clinical Oncology
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Classification of High-Grade Glioma -- Histologic Classification of High-Grade Gliomas -- Molecular Classifications -- Clinical Characteristics -- Pediatric High-Grade Glioma -- Adult High-Grade Glioma -- Diagnostic Tools for High-Grade Glioma -- Computerized Tomography -- Magnetic Resonance Imaging -- Magnetic Resonance Spectroscopy -- Imaging Tumor Biology -- Nuclear Imaging of Gliomas -- Magnetoencephalography -- Management -- General Considerations -- Surgical Techniques -- Radiation Therapy -- Brachytherapy -- Radiosurgery -- Chemotherapy -- Nursing Considerations -- Contemporary Investigational Treatments -- Convection-Enhanced Delivery -- Immunotoxins for Glioma Therapy -- Small Molecule Agents -- Cytokine Immuno-Gene Therapy for Malignant Brain Tumors -- Monoclonal Antibodies -- Clinical Trials of Oncolytic Viruses for Gliomas -- Biological Modifiers -- Gene Therapy -- Boron Neutron Capture Therapy of Brain Tumors -- Photodynamic Therapy.
520 ## - SUMMARY, ETC.
Summary, etc. This is truly an exciting time in the field of neuro-oncology, particularly in the area of hi- grade gliomas. The management of patients with high-grade gliomas has historically been one of the most challenging and disheartening fields in medicine, where failure is the rule and longevity is the exception. The jaded often state that despite purported advances in surgical and radiotherapeutic techniques and a myriad of clinical trials of medical therapies, the s- vival statistics for glioblastoma have not changed in the last three decades. The nihilism associated with these tumors is such that some practitioners still advise against treatment or even biopsy, recommending palliative care with the diagnosis based only on history and an MRI scan. If the current state-of-the-art in the diagnosis and management of high-grade gliomas was truly so bleak, there would be no reason to compile and publish a monograph on the subject. The fact is that we have recently entered an era where real progress is being made in our understanding and treatment of high-grade gliomas that is directly benefiting some patients. We are slowly but surely chipping away at this problem. One approach has exploited correlations between particular molecular markers and therapeutic response. The first such “breakthrough” in high-grade glioma was the observation that loss of chromosomes 1p and 19q uniformly predict chemosensitivity in anaplastic oligodendrogliomas (1).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neurosurgery.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Medicine & Public Health.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neurosurgery.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Barnett, Gene H.
Relator term editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781588295118
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Current Clinical Oncology
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-1-59745-185-7
912 ## -
-- ZDB-2-SME
Holdings
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Date acquired Barcode Date last seen Price effective from Koha item type
        PK Kelkar Library, IIT Kanpur PK Kelkar Library, IIT Kanpur 2016-11-21 EBK3587 2016-11-21 2016-11-21 E books

Powered by Koha